These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36205102)
41. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution. Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343 [TBL] [Abstract][Full Text] [Related]
42. Hemodynamic analysis of esophageal varices in patients with liver cirrhosis using color Doppler ultrasound. Li FH; Hao J; Xia JG; Li HL; Fang H World J Gastroenterol; 2005 Aug; 11(29):4560-5. PubMed ID: 16052688 [TBL] [Abstract][Full Text] [Related]
43. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics. Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114 [TBL] [Abstract][Full Text] [Related]
45. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats. Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782 [TBL] [Abstract][Full Text] [Related]
46. Alpha-adrenoceptor antagonists and chemical sympathectomy exacerbate anaphylaxis-induced hypotension, but not portal hypertension, in anesthetized rats. Wang M; Tanida M; Shibamoto T; Kurata Y Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(8):R900-7. PubMed ID: 23948775 [TBL] [Abstract][Full Text] [Related]
47. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation. Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068 [TBL] [Abstract][Full Text] [Related]
48. Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension. Koshy A; Sekiyama T; Hadengue A; Cerini R; Braillon A; Lebrec D J Gastroenterol Hepatol; 1992; 7(5):449-54. PubMed ID: 1391726 [TBL] [Abstract][Full Text] [Related]
49. Role of cirrhosis in the hemodynamic response to hemorrhage in portal hypertension. Burns RC; Wu Y; Sitzmann JV Surgery; 1995 May; 117(5):488-93. PubMed ID: 7740418 [TBL] [Abstract][Full Text] [Related]
50. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance. Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066 [TBL] [Abstract][Full Text] [Related]
51. Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Ohta M; Hashizume M; Higashi H; Ueno K; Tomikawa M; Kishihara F; Kawanaka H; Tanoue K; Sugimachi K Hepatology; 1994 Dec; 20(6):1432-6. PubMed ID: 7982641 [TBL] [Abstract][Full Text] [Related]
52. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin. Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773 [TBL] [Abstract][Full Text] [Related]
53. Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats. Stauber RE; Heinemann A; Trauner M; Krejs GJ Eur J Clin Invest; 1996 Aug; 26(8):676-80. PubMed ID: 8872063 [TBL] [Abstract][Full Text] [Related]
54. Hemodynamic responses to selective blockade of beta 2- and beta 1-adrenoceptors in conscious rats with cirrhosis. Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D J Hepatol; 1994 Nov; 21(5):779-86. PubMed ID: 7890894 [TBL] [Abstract][Full Text] [Related]
55. Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol. Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D Aliment Pharmacol Ther; 1997 Aug; 11(4):775-9. PubMed ID: 9305488 [TBL] [Abstract][Full Text] [Related]
56. The effects of the combination of phentolamine and vasopressin on hepatic and systemic hemodynamics in cirrhotic portal hypertensive dog model. Dan ZL; Zhao Q; Li SB J Tongji Med Univ; 1991; 11(1):35-8. PubMed ID: 1875450 [TBL] [Abstract][Full Text] [Related]
57. Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis. Turkseven S; Bolognesi M; Di Pascoli M Dig Dis Sci; 2021 Mar; 66(3):796-801. PubMed ID: 32242304 [TBL] [Abstract][Full Text] [Related]
58. Treatment of Oesophageal Varices in Liver Cirrhosis. Sauerbruch T; Wong F Digestion; 2019; 99(4):261-266. PubMed ID: 30212817 [TBL] [Abstract][Full Text] [Related]
59. Role of hepatic alpha- and beta-adrenergic receptor stimulation on hepatic glucose production during heavy exercise. Coker RH; Krishna MG; Lacy DB; Bracy DP; Wasserman DH Am J Physiol; 1997 Nov; 273(5):E831-8. PubMed ID: 9374667 [TBL] [Abstract][Full Text] [Related]
60. Long term effects of propranolol on portal pressure in cirrhotic patients. Orban-Schiopu AM; Popescu CR Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]